KPI data tables

Clover Health operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.

Clover Health Adjusted SG&A as a Percent of Revenue (Quarterly) (percent)
PeriodAdjusted SG&A % of revenue
Q3 202615
Q2 202615.1
Q1 202615.9
Q4 202520
Q3 202514.3
Q2 202517.3
Q1 202518
Q4 202425.5
Q3 202418.7
Q2 202420.1
Q1 202421.6

Source: Clover Health Form 8-K Exhibit 99.1, Adjusted SG&A as a % of Total revenues. Q1 2024 21.6% and Q1 2025 18.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 20.1% and Q2 2025 17.3%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 18.7% and Q3 2025 14.3%: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 25.5% and Q4 2025 20.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 15.9%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 15.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 15.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.

Clover Health Average Medicare Advantage Membership (Quarterly) (members)
PeriodAverage MA members
Q3 2026158,383
Q2 2026156,840
Q1 2026154,607
Q4 2025112,654
Q3 2025108,231
Q2 2025105,494
Q1 2025101,959
Q4 202482,209
Q3 202480,753
Q2 202480,016
Q1 202479,265

Source: Clover Health Form 8-K Exhibit 99.1, Average Medicare Advantage membership. Q1 2024 79,265 and Q1 2025 101,959: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 80,016 and Q2 2025 105,494: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 80,753 and Q3 2025 108,231: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82,209 and Q4 2025 112,654: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 154,607: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 156,840: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 158,383: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.

Clover Health Cash, Cash Equivalents, and Investments (Quarterly) (usd_millions)
PeriodCash, cash equivalents, and investments
Q3 2026512.6
Q2 2026443
Q1 2026418.2
Q4 2025319.9
Q3 2025395.9
Q2 2025389.3
Q1 2025390.8
Q4 2024437.6
Q3 2024531.4
Q2 2024482.8
Q1 2024440.3

Source: Clover Health Form 8-K Exhibit 99.1, Total cash, cash equivalents, and investments. Q1 2024 440.3 and Q1 2025 390.8: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 482.8 and Q2 2025 389.3: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 531.4 and Q3 2025 395.9: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 437.6 and Q4 2025 319.9: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 418.2: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 443.0: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 512.6: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.

Clover Health Insurance Benefits Expense Ratio (Benefit Expense Ratio) (percent)
PeriodInsurance BER
Q3 202691.1
Q2 202687.6
Q1 202686.5
Q4 202595
Q3 202593.5
Q2 202588.4
Q1 202586.1
Q4 202482.8
Q3 202482.8
Q2 202476.1
Q1 202483.2

Source: Clover Health Form 8-K Exhibit 99.1, Insurance Segment Insurance BER. Q1 2024 83.2% and Q1 2025 86.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 76.1% and Q2 2025 88.4%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 82.8% and Q3 2025 93.5%: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82.8% and Q4 2025 95.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 86.5%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 87.6%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 91.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.

Clover Health Lives under Management: Insurance vs Non-Insurance (lives)
PeriodInsurance (Medicare Advantage)Non-Insurance (DCE / ACO REACH)
FY 2025113,8030
FY 202482,6640
FY 202381,20550,529
FY 202288,627164,887
FY 202168,12061,876

Source: Clover Health Form 8-K Exhibit 99.1, Lives under Clover Management. FY 2021 Insurance 68,120 and DCE 61,876: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000011/a12312021-earningsrelease.htm. FY 2022 Insurance 88,627 and Non-Insurance 164,887, FY 2023 Insurance 81,205 and Non-Insurance 50,529: https://investors.cloverhealth.com/static-files/01a3ac32-054a-4723-80c7-b0721d7a3ea3. FY 2024 Insurance 82,664: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000049/aexx991xearningsreleasex4q.htm. FY 2025 Insurance 113,803: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm.

Clover Health Medicare Advantage Members (Period-End) (members)
PeriodPeriod-end MA members
Q3 2026158,907
Q2 2026157,309
Q1 2026155,773
Q4 2025113,803
Q3 2025109,226
Q2 2025106,323
Q1 2025103,418
Q4 202482,664
Q3 202481,110
Q2 202480,261
Q1 202479,527

Source: Clover Health Form 8-K Exhibit 99.1, Lives under Clover Management. Q1 2024 79,527 and Q1 2025 103,418: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 80,261 and Q2 2025 106,323: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 81,110 and Q3 2025 109,226: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82,664 and Q4 2025 113,803: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 155,773: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 157,309: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 158,907: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites
Clover Health (CLOV) - KPIs | Sterling